Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER Study [6]

Thrombosis and Haemostasis

Volumn 99, Issue 1, 2008, Pages 246-248

  Canonico, Marianne ^a,b   Olié, Valerie ^a,b   Carcaillon, Laure ^a,b   Tubert Bitter, Pascale ^a,b   Scarabin, Pierre Yves ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; BLOOD CLOTTING FACTOR 5 LEIDEN; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GUANINE; PROTHROMBIN;

ADULT; AGED; BLOOD GROUP ABO SYSTEM; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESTROGEN THERAPY; FAMILY HISTORY; FEMALE; FRANCE; GENE MUTATION; HIGH RISK POPULATION; HUMAN; LETTER; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OBESITY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; VARICOSIS; VENOUS THROMBOEMBOLISM;

ABO BLOOD-GROUP SYSTEM; ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; RISK ASSESSMENT; RISK FACTORS; VARICOSE VEINS; VENOUS THROMBOEMBOLISM;

EID: 38349114395     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-09-0536     Document Type: Letter

References (13)

1. Jick H, Slone D, Westerholm B, et al. Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet 1969; 1: 539-542.
2. Wautrecht JC, Galle C, Motte S, et al. The role of ABO blood groups in the incidence of deep vein thrombosis. Thromb Haemost 1998; 79: 688-689.
3. Robert A, Aillaud MF, Eschwege V, et al. ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden. Thromb Haemost 2000; 83: 630-631.
4. Morelli VM, de Visser MC, van Tilburg NH, et al. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens. Thromb Haemost 2007; 97: 534-541.
5. Tirado I, Mateo J, Soria JM, et al. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost 2005; 93: 468-474.
6. Mercier B, Oger E, Le Gal G, et al. Phenotypic but not allelic ABO blood group association with risk of venous thrombosis. Thromb Haemost 2005; 93: 388-389.
7. Morelli VM, De Visser MC, Vos HL, et al. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost 2005; 3: 183-185.
8. Ohira T, Cushman M, Tsai MY, et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 2007; 5: 1455-1461.
9. Scarabin PY, Oger E, Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 2003; 362: 428-432.
10. Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007; 115: 840-845.
11. Straczek C, Oger E, Yon de Jonage-Canonico MB, et al. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration. Circulation 2005; 112: 3495-500.
12. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992; 3: 452-6.
13. Ito H, Matsuo K, Saito T, et al. Valid responses to ABO blood type question in self-reporting questionnaire. Asian Pac J Cancer Prev 2001; 2: 315-317.